patents.google.com

GB2388190B - Methods for measuring enzyme activity - Google Patents

  • ️Wed Nov 17 2004

GB2388190B - Methods for measuring enzyme activity - Google Patents

Methods for measuring enzyme activity

Info

Publication number
GB2388190B
GB2388190B GB0308910A GB0308910A GB2388190B GB 2388190 B GB2388190 B GB 2388190B GB 0308910 A GB0308910 A GB 0308910A GB 0308910 A GB0308910 A GB 0308910A GB 2388190 B GB2388190 B GB 2388190B Authority
GB
United Kingdom
Prior art keywords
enzyme activity
measuring enzyme
methods
relates
measuring
Prior art date
2002-04-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0308910A
Other versions
GB0308910D0 (en
GB2388190A (en
Inventor
John Gerard Whateley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare UK Ltd
Original Assignee
Amersham Biosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2002-04-19
Filing date
2003-04-17
Publication date
2004-11-17
2003-04-17 Application filed by Amersham Biosciences UK Ltd filed Critical Amersham Biosciences UK Ltd
2003-04-17 Priority to GB0409330A priority Critical patent/GB2398123B/en
2003-05-21 Publication of GB0308910D0 publication Critical patent/GB0308910D0/en
2003-11-05 Publication of GB2388190A publication Critical patent/GB2388190A/en
2004-11-17 Application granted granted Critical
2004-11-17 Publication of GB2388190B publication Critical patent/GB2388190B/en
2023-04-17 Anticipated expiration legal-status Critical
Status Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/9015—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to fluorescence methods for measuring enzyme activity, in particular enzyme cleaving and joining activities. The invention also relates to fluorogenic substrates which are useful for measuring enzyme activity and as in vitro and in vivo imaging probes.

GB0308910A 2002-04-19 2003-04-17 Methods for measuring enzyme activity Expired - Fee Related GB2388190B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0409330A GB2398123B (en) 2002-04-19 2003-04-17 Methods for measuring enzyme activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0208989.4A GB0208989D0 (en) 2002-04-19 2002-04-19 Methods for measuring enzyme activity

Publications (3)

Publication Number Publication Date
GB0308910D0 GB0308910D0 (en) 2003-05-21
GB2388190A GB2388190A (en) 2003-11-05
GB2388190B true GB2388190B (en) 2004-11-17

Family

ID=9935152

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0208989.4A Ceased GB0208989D0 (en) 2002-04-19 2002-04-19 Methods for measuring enzyme activity
GB0308910A Expired - Fee Related GB2388190B (en) 2002-04-19 2003-04-17 Methods for measuring enzyme activity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0208989.4A Ceased GB0208989D0 (en) 2002-04-19 2002-04-19 Methods for measuring enzyme activity

Country Status (9)

Country Link
US (2) US7727739B2 (en)
EP (1) EP1497452B1 (en)
JP (1) JP4713835B2 (en)
AT (1) ATE500342T1 (en)
AU (1) AU2003229914A1 (en)
CA (1) CA2484467C (en)
DE (1) DE60336217D1 (en)
GB (2) GB0208989D0 (en)
WO (1) WO2003089663A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113434D0 (en) * 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Quinacridone derivatives as labels for fluorescence detection of biological materials
JP4637565B2 (en) * 2004-11-02 2011-02-23 一般社団法人オンチップ・セロミクス・コンソーシアム Biological sample labeling and biological substance labeling method and biological substance inspection method
US20090220587A1 (en) * 2005-02-01 2009-09-03 United State Army Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands
US7741431B2 (en) * 2005-02-01 2010-06-22 The United States Of America As Represented By The Secretary Of The Army Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
EP1900822B1 (en) * 2005-05-24 2016-02-03 Suzuki, Miho Method for simultaneous analysis of multiple biological reactions or changes in in vivo conditions
WO2007049057A2 (en) * 2005-10-28 2007-05-03 Iti Scotland Limited Novel fluorescent dyes and uses thereof
US8691939B2 (en) 2007-06-08 2014-04-08 General Electric Company Compositions, methods, and kits for assaying complement activation
WO2009112791A1 (en) * 2008-03-14 2009-09-17 Assaymetrics Limited Fluorogenic peptides and their method of production
JP2010215572A (en) * 2009-03-17 2010-09-30 Japan Health Science Foundation Pulpitis diagnostic marker and pulpitis diagnostic system
JP5697129B2 (en) * 2010-03-24 2015-04-08 国立大学法人埼玉大学 Enzyme activity measurement substrate using FRET and method for producing the same
WO2012110833A2 (en) 2011-02-18 2012-08-23 Almac Sciences (Scotland) Limited Fluorescence modulators
US9180209B2 (en) 2011-02-28 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Non-peptidic quenched fluorescent imaging probes
JP2014508537A (en) 2011-03-25 2014-04-10 アルマック・サイエンシーズ・（スコットランド）・リミテッド Enzyme assay
EP2718719B1 (en) * 2011-06-07 2018-10-17 Life Technologies Corporation Fluorogenic semiconductor nanocrystals
KR101372632B1 (en) 2011-08-26 2014-03-14 동국대학교 산학협력단 Method for analysis of xpg endonuclease activity
GB201122099D0 (en) 2011-12-22 2012-02-01 Almac Sciences Scotland Ltd Dyes
WO2013142758A1 (en) 2012-03-23 2013-09-26 Surmodics, Inc. Compositions and methods for in vitro diagnostic tests including sulfonic acid
RU2622753C1 (en) * 2016-11-17 2017-06-19 Федеральное государственное бюджетное учреждение "Национальный научно-практический центр сердечно-сосудистой хирургии имени А.Н. Бакулева" Министерства здравоохранения Российской Федерации (ФГБУ "ННПЦССХ им. А.Н. Бакулева" Минздрава России) Method for angiotensin converting enzyme activity determination in heart tissues
CN114605405B (en) * 2022-03-09 2023-09-05 吉林大学 A quinacridone skeleton-based fluorescent imaging probe for cell lipid droplets and its application

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428000A1 (en) * 1989-11-03 1991-05-22 Abbott Laboratories Fluorogenic substrates for the detection of proteolytic enzyme activity
WO1991016336A1 (en) * 1990-04-17 1991-10-31 Carlsberg A/S Fluorogenic peptides and their use in the determination of enzymatic activities
WO1995025093A1 (en) * 1994-03-14 1995-09-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Acridone-derived bisintercalators as chemotherapeutic agents
US5708137A (en) * 1994-04-29 1998-01-13 G.D. Searle & Co. Reagent and method for determining activity of herpes protease
WO1998029562A2 (en) * 1996-12-27 1998-07-09 Boehringer Ingelheim (Canada) Ltd. Improved substrates for human cytomegalovirus protease
WO2002081509A2 (en) * 2001-04-06 2002-10-17 WOLFRUM, Jürgen Specific detection of proteolytic enzymes using a hybrid protein

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7801373L (en) * 1978-02-07 1979-08-08 Kabi Ab EASY SPLABLE SUBSTRATE FOR QUANTIFIATION OF PROTEASES
EP0078764B1 (en) 1981-11-02 1986-01-02 Pentapharm A.G. Process for the quantitative determination of the blood clotting factor xii in human plasma
US4812409A (en) 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
FR2635114A1 (en) * 1988-08-02 1990-02-09 Cibevial Sa PROCESS FOR THE TREATMENT OF PROTEIN SOLUTIONS CONTAINING PIGMENTS SUCH AS HEMINIC OR CHLOROPHYLLIC GROUPS FOR THEIR DECOLORATION AND PRODUCTS OBTAINED
GB9310978D0 (en) 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
CA2211470A1 (en) 1995-01-30 1996-08-08 Daiichi Pure Chemicals Co., Ltd. Diagnostic marker
US20010004522A1 (en) 1997-10-28 2001-06-21 Thomas J. Burke Kinase activity measurement using fluorescence polarization
DE19717904A1 (en) 1997-04-23 1998-10-29 Diagnostikforschung Inst Acid-labile and enzymatically cleavable dye constructs for diagnostics with near infrared light and for therapy
EP0998577B1 (en) 1997-07-24 2004-10-27 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
US6133445A (en) 1997-12-17 2000-10-17 Carnegie Mellon University Rigidized trimethine cyanine dyes
US6251583B1 (en) 1998-04-27 2001-06-26 Schering Corporation Peptide substrates for HCV NS3 protease assays
JP2002542453A (en) * 1998-08-08 2002-12-10 インペリアル キャンサー リサーチ テクノロジー リミテッド Fluorescence analysis of biological systems
US6447724B1 (en) * 1998-08-11 2002-09-10 Caliper Technologies Corp. DNA sequencing using multiple fluorescent labels being distinguishable by their decay times
US6207831B1 (en) 1998-12-21 2001-03-27 Novartis Ag Fluorescent dyes (AIDA) for solid phase and solution phase screening
GB9901072D0 (en) * 1999-01-19 1999-03-10 Imp Cancer Res Tech Methods for detecting changes to a macromolecular component of a cell
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
EP1185644A1 (en) 1999-05-27 2002-03-13 Merck Frosst Canada & Co. Assays for caspase activity using green fluorescent proteins
US6323186B1 (en) 1999-09-17 2001-11-27 Molecular Probes, Inc. Phosphate-bound polyazaindacene derivatives of nucleotides
GB2357084A (en) 1999-12-06 2001-06-13 Amersham Pharm Biotech Uk Ltd A hydrophobic carrier peptide
WO2002056670A2 (en) 2001-01-05 2002-07-25 The General Hospital Corporation Activatable imaging probes
GB0113434D0 (en) 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Quinacridone derivatives as labels for fluorescence detection of biological materials
GB0113435D0 (en) 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Acridone derivatives as labels for fluorescence detection of target materials

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428000A1 (en) * 1989-11-03 1991-05-22 Abbott Laboratories Fluorogenic substrates for the detection of proteolytic enzyme activity
WO1991016336A1 (en) * 1990-04-17 1991-10-31 Carlsberg A/S Fluorogenic peptides and their use in the determination of enzymatic activities
WO1995025093A1 (en) * 1994-03-14 1995-09-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Acridone-derived bisintercalators as chemotherapeutic agents
US5708137A (en) * 1994-04-29 1998-01-13 G.D. Searle & Co. Reagent and method for determining activity of herpes protease
WO1998029562A2 (en) * 1996-12-27 1998-07-09 Boehringer Ingelheim (Canada) Ltd. Improved substrates for human cytomegalovirus protease
WO2002081509A2 (en) * 2001-04-06 2002-10-17 WOLFRUM, Jürgen Specific detection of proteolytic enzymes using a hybrid protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Anal. Biochem., Vol.195, 1991, Meldal, M. et al., "Anthranilamide and nitrotyrosine...", pp.141-147. *
Biochem. Biophys. Res. Comm., Vol.201, 1994, Wang, W. et al., "Fluorogenic peptides...", pp.835-840. *

Also Published As

Publication number Publication date
GB0308910D0 (en) 2003-05-21
JP2005527212A (en) 2005-09-15
CA2484467C (en) 2012-01-10
EP1497452B1 (en) 2011-03-02
US7727739B2 (en) 2010-06-01
US20030228609A1 (en) 2003-12-11
GB0208989D0 (en) 2002-05-29
US20100184098A1 (en) 2010-07-22
EP1497452A2 (en) 2005-01-19
DE60336217D1 (en) 2011-04-14
CA2484467A1 (en) 2003-10-30
WO2003089663A2 (en) 2003-10-30
ATE500342T1 (en) 2011-03-15
JP4713835B2 (en) 2011-06-29
WO2003089663A3 (en) 2004-05-27
GB2388190A (en) 2003-11-05
AU2003229914A1 (en) 2003-11-03

Similar Documents

Publication Publication Date Title
GB2388190B (en) 2004-11-17 Methods for measuring enzyme activity
WO2004029219A3 (en) 2004-07-01 Cell-based rna interference and related methods and compositions
IL179441A (en) 2010-12-30 Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzyme
TW200621253A (en) 2006-07-01 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
TW200640482A (en) 2006-12-01 Variant forms of urate oxidase and use thereof
WO2007047766A3 (en) 2008-12-24 Methods for rejuvenating cells in vitro and in vivo
WO2006131928A8 (en) 2007-07-19 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2004055519A3 (en) 2004-11-04 Specific markers for pancreatic cancer
EP1970443A4 (en) 2010-11-17 Carrier for making immobilized enzyme or immobilized cells and method of using the same
AU2002365365A1 (en) 2003-06-10 Metal complex compounds
DE602006017882D1 (en) 2010-12-09 COMPOSITIONS AND METHODS FOR INCREASING THE PRODUCTION OF RECOMBINANT GAMMA-CARBOXYLATED PROTEINS
WO2008033427A3 (en) 2008-07-31 Compositions and methods for detection of lysosomal storage disease
WO2007075910A3 (en) 2007-12-06 Methods and compositions for detecting enzymatic activity
WO2008019069A3 (en) 2008-06-05 Enzymatic aqueous acylation
MX2008002123A (en) 2008-04-17 Methods and compositions for determining a level of biologically active serum paraoxonase.
WO2005123913A3 (en) 2009-04-02 Reversibly modified thermostable enzyme compositions and methods of making and using the same
ATE256120T1 (en) 2003-12-15 REAGENTS FOR CYP2D FLUORESCENCE TEST
WO2003093438A3 (en) 2004-07-01 Human adipocyte cell populations and methods for identifying modulators of same
WO2006104761A3 (en) 2007-04-26 Unique sequence hybridization probes (usp)
WO2004063339A3 (en) 2005-07-21 G-quadruplex binding assays and compounds therefor
WO2004043991A3 (en) 2004-07-15 Assay for tissue factor and factor viia
WO2007010145A3 (en) 2007-03-15 Saccharide fluorescent substrates, preparation method and uses thereof
WO2008095995A3 (en) 2009-01-08 Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin ii
WO2008100244A3 (en) 2009-01-08 Methods of detecting mutations associated with ataxia-ocular apraxia 2 (aoa2)
WO2006022682A3 (en) 2006-09-08 Method and compositions for treating diseases targeting cd49b

Legal Events

Date Code Title Description
2013-12-25 PCNP Patent ceased through non-payment of renewal fee

Effective date: 20130417